Woodline Partners »

Kymera Therapeutics shares owned by Woodline Partners

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $20M 501k 40.20
2023-09-30 $1.4M 103k 13.90
2023-06-30 $2.5M 109k 22.99
2023-03-31 $3.0M 100k 29.63
2022-12-31 $2.5M 100k 24.96
2022-09-30 $2.2M 100k 21.77
2022-06-30 $2.0M 100k 19.69
2021-09-30 $7.6M 129k 58.74
2021-06-30 $1.8M 38k 48.49
2020-12-31 $11M 170k 62.00
2020-09-30 $5.4M 166k 32.31